#None #financial results #Northbrook #Stepan Company #SCL

Stepan Company Reports Financial Results for Q4 and Full Year 2025

Stepan Company, traded on the NYSE as SCL, has disclosed its financial outcomes for the fourth quarter and the entire year of 2025, marking a year of notable developments. The company's reported net income for the fourth quarter reached $5.0 million, a striking increase of 49% compared to the previous year. However, several challenges impacted adjusted net income, which showed a loss of $0.5 million, marking a 119% decrease year-over-year.

Fourth Quarter Highlights

During Q4 2025, Stepan Company experienced a growth in EBITDA, which surged to $43.3 million, up 21% from the same quarter last year. Despite this growth, adjusted EBITDA decreased by 3%, totaling $33.8 million.

Interestingly, the global sales volume revealed a 3% decline when compared to the previous year. This drop was primarily influenced by the divestiture of the Philippines asset, but excluding this factor, sales volumes remained stable. The company reported an impressive $60.0 million in cash from operations for the quarter, and free cash flow was noted at $25.4 million, indicating robust operational dynamics stemming from reduced working capital.

Pre-tax earnings for the quarter included a goodwill impairment expense of $6.2 million relating to its Mexican reporting unit, alongside $15.9 million in gains stemming from earlier mentioned asset divestitures.

Full Year Overview

In a broader view, the company’s overall performance for the full year indicated a reported net income of $46.9 million, which reflected a 7% decrease compared to 2024. Adjusted net income also fell to $41.7 million, down 17% year-over-year.

For the year, Stepan reported $208.0 million in EBITDA, while adjusted EBITDA amounted to $198.9 million, marking an 11% and 6% increase respectively. Sales volume exhibited a 1% rise, while excluding the impact of the Philippines asset divestiture, it indicated a 2% increase.

Luis E. Rojo, President and CEO, noted that 2025 was a transformative year for Stepan. The company undertook significant actions, including the divestment of two plant sites which laid the groundwork for future optimization and growth. Despite the prevailing challenges in the market, several core businesses achieved growth and strategic initiatives were advanced, providing a solid platform for profitable expansion moving forward.

Market Dynamics and Strategic Outlook

Despite the upward trajectory in sales volume, particularly in the polymer segment which saw an 11% increase, the surfactant sector faced difficulties marked by declining margins driven by rising raw material costs. Rojo expressed gratitude to Stepan staff for their resilience and dedication during a challenging year.

Moving into 2026, the company aims for enhanced shareholder returns through initiatives like Project Catalyst, a comprehensive plan designed to optimize its asset base and achieve increased productivity. This project is expected to deliver around $100 million in pre-tax savings over the next two years, alongside a focus on improving operational efficiency.

The company is set to consolidate its operations, including the potential closure of its Fieldsboro, NJ facility while also decommissioning certain assets in Millsdale, IL and Stalybridge, UK.

Conclusion

As Stepan Company navigates through a complex market landscape, its efforts in strategic divestitures and a strong operational plan illustrate a commitment to adaptability and growth, aiming to enhance profitability amid the ongoing market challenges. Stakeholders can expect a conservative yet optimistic outlook for 2026 as the firm actively seeks further enhancements in efficiency and market positioning.